Cargando…

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock

BACKGROUND: Polymyxin B-immobilized fiber column hemoperfusion (PMX) has been reported to be effective for patients with septic shock. It remains unclear, however, how the efficacy of PMX varies according to the characteristics and underlying conditions of the patients treated. The objective of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiura, Makiko, Mitaka, Chieko, Haraguchi, Go, Tomita, Makoto, Inase, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392791/
https://www.ncbi.nlm.nih.gov/pubmed/25866644
http://dx.doi.org/10.1186/s40560-015-0080-9
_version_ 1782366047794364416
author Sugiura, Makiko
Mitaka, Chieko
Haraguchi, Go
Tomita, Makoto
Inase, Naohiko
author_facet Sugiura, Makiko
Mitaka, Chieko
Haraguchi, Go
Tomita, Makoto
Inase, Naohiko
author_sort Sugiura, Makiko
collection PubMed
description BACKGROUND: Polymyxin B-immobilized fiber column hemoperfusion (PMX) has been reported to be effective for patients with septic shock. It remains unclear, however, how the efficacy of PMX varies according to the characteristics and underlying conditions of the patients treated. The objective of the present study was to clarify the factors that result in clinical efficacy of PMX treatment. METHODS: We retrospectively investigated 78 consecutive patients with severe sepsis or septic shock who underwent PMX treatment. We reviewed the demographic data, routine biochemistry, microbiological data, infection focus, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure Assessment (SOFA) score, change in mean arterial pressure (MAP), inotropic score, vasopressor dependency index, plasma levels of endotoxin and lactate, PaO(2)/F(I)O(2) ratio, and survival time. We also divided the patients into two groups for comparison, namely, those whose inotropic scores improved after PMX treatment (improvement group) and those whose inotropic scores did not improve (non-improvement group). RESULTS: The inotropic score and the vasopressor dependency index significantly decreased from 18.1 to 9.9 (p < 0.05) and from 0.27 to 0.14 (p < 0.05), respectively, after PMX treatment in the overall study population, while no significant change in the PaO(2)/F(I)O(2) ratio was observed (p = 0.96). The inotropic score at pre-PMX treatment was significantly higher in the improvement group than in the non-improvement group (p < 0.01). The improvement of the PaO(2)/F(I)O(2) ratio after PMX treatment was significant in the improvement group (p < 0.05). CONCLUSIONS: The improvement group’s inotropic score was higher, because of peripheral blood vessels dilatation and requirement for more catecholamines. Therefore, our study suggests that PMX treatment is particularly useful for improving hemodynamics in septic shock patients with excessively dilated peripheral blood vessels.
format Online
Article
Text
id pubmed-4392791
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43927912015-04-11 Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock Sugiura, Makiko Mitaka, Chieko Haraguchi, Go Tomita, Makoto Inase, Naohiko J Intensive Care Research BACKGROUND: Polymyxin B-immobilized fiber column hemoperfusion (PMX) has been reported to be effective for patients with septic shock. It remains unclear, however, how the efficacy of PMX varies according to the characteristics and underlying conditions of the patients treated. The objective of the present study was to clarify the factors that result in clinical efficacy of PMX treatment. METHODS: We retrospectively investigated 78 consecutive patients with severe sepsis or septic shock who underwent PMX treatment. We reviewed the demographic data, routine biochemistry, microbiological data, infection focus, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure Assessment (SOFA) score, change in mean arterial pressure (MAP), inotropic score, vasopressor dependency index, plasma levels of endotoxin and lactate, PaO(2)/F(I)O(2) ratio, and survival time. We also divided the patients into two groups for comparison, namely, those whose inotropic scores improved after PMX treatment (improvement group) and those whose inotropic scores did not improve (non-improvement group). RESULTS: The inotropic score and the vasopressor dependency index significantly decreased from 18.1 to 9.9 (p < 0.05) and from 0.27 to 0.14 (p < 0.05), respectively, after PMX treatment in the overall study population, while no significant change in the PaO(2)/F(I)O(2) ratio was observed (p = 0.96). The inotropic score at pre-PMX treatment was significantly higher in the improvement group than in the non-improvement group (p < 0.01). The improvement of the PaO(2)/F(I)O(2) ratio after PMX treatment was significant in the improvement group (p < 0.05). CONCLUSIONS: The improvement group’s inotropic score was higher, because of peripheral blood vessels dilatation and requirement for more catecholamines. Therefore, our study suggests that PMX treatment is particularly useful for improving hemodynamics in septic shock patients with excessively dilated peripheral blood vessels. BioMed Central 2015-03-20 /pmc/articles/PMC4392791/ /pubmed/25866644 http://dx.doi.org/10.1186/s40560-015-0080-9 Text en © Sugiura et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sugiura, Makiko
Mitaka, Chieko
Haraguchi, Go
Tomita, Makoto
Inase, Naohiko
Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
title Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
title_full Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
title_fullStr Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
title_full_unstemmed Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
title_short Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
title_sort polymyxin b-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392791/
https://www.ncbi.nlm.nih.gov/pubmed/25866644
http://dx.doi.org/10.1186/s40560-015-0080-9
work_keys_str_mv AT sugiuramakiko polymyxinbimmobilizedfibercolumnhemoperfusionmainlyhelpstoconstrictperipheralbloodvesselsintreatmentforsepticshock
AT mitakachieko polymyxinbimmobilizedfibercolumnhemoperfusionmainlyhelpstoconstrictperipheralbloodvesselsintreatmentforsepticshock
AT haraguchigo polymyxinbimmobilizedfibercolumnhemoperfusionmainlyhelpstoconstrictperipheralbloodvesselsintreatmentforsepticshock
AT tomitamakoto polymyxinbimmobilizedfibercolumnhemoperfusionmainlyhelpstoconstrictperipheralbloodvesselsintreatmentforsepticshock
AT inasenaohiko polymyxinbimmobilizedfibercolumnhemoperfusionmainlyhelpstoconstrictperipheralbloodvesselsintreatmentforsepticshock